A new decade is here. And despite the incredible science, pharma is ill-equipped.
There is a new surge of interest in telemedicine’s potential to optimize clinical trials, but is this what patients want?
From site-in-a-box to virtual/siteless trials: which new model will successfully disrupt clinical research?
Putting the patient at the centre of clinical trials could be transformative